Lebanon vs Mali: Cause of death, by non-communicable diseases, ages 15-59, female
Lebanon
44.9%
in 2021
Mali
45.5%
in 2021
Lebanon rank
151st
Mali rank
149th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Lebanon
- Mali
How they compare
Mali currently reports 45.5% against 44.9% in Lebanon, a difference of 0.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Lebanon ahead.
Lebanon ranks 151st and Mali ranks 149th of 185 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lebanon | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.4% | 34.9% | 41.6% | Lebanon |
| 2010s | 81.0% | 43.4% | 37.5% | Lebanon |
| 2020s | 58.0% | 45.4% | 12.6% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Lebanon or Mali?
- Mali, at 45.5% against 44.9% in Lebanon as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Lebanon and Mali?
- 0.6%, with Mali ahead.
- How many years of comparable data are there for Lebanon and Mali?
- 6 years are reported by both, from 2000 to 2021.
- How do Lebanon and Mali rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Lebanon ranks 151st and Mali ranks 149th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.